The JAX Blog

Learn about new technologies and discoveries focused on precise and personalized treatments for patients.

Blog Post: Catherine Hagan, D.V.M., Ph.D. January 03, 2017

In the fight over the CRISPR patent, JAX customers win

The Jackson Laboratory has obtained patent licenses from both The Broad Institute and Caribou Biosciences to provide customers with rights under patents covering the CRISPR Cas9 process to use new mouse models created at JAX with CRISPR-Cas9 for most internal research. Thus, no matter which of the two parties wins the high profile, high stakes dispute over who owns patent rights to the genome editing technology, JAX customers will be protected.

Read the Article